Real-world Treatment Patterns and Clinical Outcomes in EGFR-mutant Unresectable Locally Advanced NSCLC

NCT04304638 · clinicaltrials.gov ↗

UNKNOWN

Status

450

Enrollment

OTHER

Sponsor class

Conditions

Non Small Cell Lung Cancer
Stage III Non-small-cell Lung Cancer
EGFR Mutation-Related Tumors

Interventions

RADIATION: radiation or chemo-radiation
DRUG: EGFR-TKI Inhibitor

Sponsor

Chinese Academy of Medical Sciences